Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2018

Open Access 01-12-2018 | Guidelines article

World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals

Authors: Awa Aidara-Kane, Frederick J. Angulo, John M. Conly, Yuki Minato, Ellen K. Silbergeld, Scott A. McEwen, Peter J. Collignon, for the WHO Guideline Development Group

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2018

Login to get access

Abstract

Background

Antimicrobial use in food-producing animals selects for antimicrobial resistance that can be transmitted to humans via food or other transmission routes. The World Health Organization (WHO) in 2005 ranked the medical importance of antimicrobials used in humans. In late 2017, to preserve the effectiveness of medically important antimicrobials for humans, WHO released guidelines on use of antimicrobials in food-producing animals that incorporated the latest WHO rankings.

Methods

WHO commissioned systematic reviews and literature reviews, and convened a Guideline Development Group (GDG) of external experts free of unacceptable conflicts-of-interest. The GDG assessed the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, and formulated recommendations using a structured evidence-to-decision approach that considered the balance of benefits and harms, feasibility, resource implications, and impact on equity. The resulting guidelines were peer-reviewed by an independent External Review Group and approved by the WHO Guidelines Review Committee.

Results

These guidelines recommend reductions in the overall use of medically important antimicrobials in food-producing animals, including complete restriction of use of antimicrobials for growth promotion and for disease prevention (i.e., in healthy animals considered at risk of infection). These guidelines also recommend that antimicrobials identified as critically important for humans not be used in food-producing animals for treatment or disease control unless susceptibility testing demonstrates the drug to be the only treatment option.

Conclusions

To preserve the effectiveness of medically important antimicrobials, veterinarians, farmers, regulatory agencies, and all other stakeholders are urged to adopt these recommendations and work towards implementation of these guidelines.
Literature
3.
go back to reference Molbak K. Human health consequences of antimicrobial rug-resistant salmonella and other foodborne pathogens. Clin Infect Dis. 2005;4:1613–20. Molbak K. Human health consequences of antimicrobial rug-resistant salmonella and other foodborne pathogens. Clin Infect Dis. 2005;4:1613–20.
13.
go back to reference Angulo FJ, Nargund VN, Chiller TC. Evidence of an association between use of antimicrobial agents in food animals and antimicrobial resistance among bacteria isolated from humans and the human health consequences of such resistance. J Vet Med Series B Infect Dis Vet Public Health. 2004;51(8-9):374–9.CrossRef Angulo FJ, Nargund VN, Chiller TC. Evidence of an association between use of antimicrobial agents in food animals and antimicrobial resistance among bacteria isolated from humans and the human health consequences of such resistance. J Vet Med Series B Infect Dis Vet Public Health. 2004;51(8-9):374–9.CrossRef
18.
go back to reference Tang KL, Caffrey NP, Nóbrega DB, et al. Restriction in the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and humans – a systematic review and meta-analysis. Lancet Planetary Health In press. Tang KL, Caffrey NP, Nóbrega DB, et al. Restriction in the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and humans – a systematic review and meta-analysis. Lancet Planetary Health In press.
19.
go back to reference Webb HE, Angulo FJ, Granier SA, Scott HM, Loneragan GH. Illustrative examples of probable transfer of resistance determinants from food animals to humans: Streptothricins, glycopeptides, and coliston. F1000Research. 2017;6:1805. doi:10.126888/11000research.12777.1CrossRefPubMedPubMedCentral Webb HE, Angulo FJ, Granier SA, Scott HM, Loneragan GH. Illustrative examples of probable transfer of resistance determinants from food animals to humans: Streptothricins, glycopeptides, and coliston. F1000Research. 2017;6:1805. doi:10.126888/11000research.12777.1CrossRefPubMedPubMedCentral
20.
go back to reference Swann MM. Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine (Swann report). London: Her Majesty’s Stationery Office; 1969. Swann MM. Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine (Swann report). London: Her Majesty’s Stationery Office; 1969.
28.
go back to reference Norris SL, Ford N. Improving the quality of WHO guidelines over the last decade: progress and challenges. Lancet. 2017;5:e855–6. Norris SL, Ford N. Improving the quality of WHO guidelines over the last decade: progress and challenges. Lancet. 2017;5:e855–6.
Metadata
Title
World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals
Authors
Awa Aidara-Kane
Frederick J. Angulo
John M. Conly
Yuki Minato
Ellen K. Silbergeld
Scott A. McEwen
Peter J. Collignon
for the WHO Guideline Development Group
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2018
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-017-0294-9

Other articles of this Issue 1/2018

Antimicrobial Resistance & Infection Control 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.